malignant tumor of the lung atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Niigata University Graduate School of Medical and Dental Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who are scheduled for surgery for left malignant pulmonary tumor (suspected or confirmed) 2.surgical procedure: segmentectomy >= 3.non-valvular atrial fibrillation 4.20 years <= 5.ECOG performance status of 0 or 1 6. No following surgical history i) left thoracotomy ii) left thoracoscopic resection of lung, esophagus, and mediastinum (except for thoracoscopic resection of bullae) iii) Heart and great vessel surgery (except for thoracic endovascular aortic repair) 7.Written informed consent
Exclusion criteria
Exclusion criteria: 1.Active infection requiring systemic therapy 2. Female during pregnancy, within 28 days of postparturition, or during lactation and male expecting partner's pregnancy 3.Severe psychological disorder 4.History of myocardial infarction or attack of angina pectoris within the past 3 weeks 5.Uncontrollable valvular disease, dilated cardiomyopathy, and hypertrophic cardiomyopathy 6.Interstitial pneumonitis 7.thrombus in left atrial appendage 8.No radiotherapy at the site of operation 9. a participating surgeon judged that the patient was not appropriate candidate for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time Bleeding volume length of drainage tube placement length of hospital stay | — |
Countries
Japan
Contacts
Public ContactTatsuya Goto
Niigata University Graduate School of Medical and Dental Sciences Division of Thoracic and Cardiovascular Surgery
Outcome results
None listed